# Cardiovascular Risk Comparison Between Expanded Hemodialysis Using Theranova and On-line Hemodiafiltration

> **NCT03448887** · NA · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 80 (actual)

## Conditions studied

- Kidney Failure, Chronic
- Renal Dialysis

## Interventions

- **DEVICE:** Theranova
- **DEVICE:** Online hemodiafiltration

## Key facts

- **NCT ID:** NCT03448887
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-15
- **Primary completion:** 2020-07-15
- **Final completion:** 2020-08-31
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2020-10-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03448887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03448887, "Cardiovascular Risk Comparison Between Expanded Hemodialysis Using Theranova and On-line Hemodiafiltration". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03448887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*